Table 5.

Response and survival outcomes in both groups

	BuCyE	BEAM	P value
Refractory, number of patients (%)	2 (6.5%)	0 (0%)	1.000
Complete Remission, number of patients (%)	21 (67.7%)	7 (63.6%)	1.000
Relapse, number of patients (%)	3 (9.7%)	1 (9.1%)	1.000
Event Free Survival, mean ± sem, months	29.91±2.69	47.13±2.69	0.420
Disease related mortality, number of patients (%)	3 (33.3%)	0 (0%)	0.509
Non disease related mortality, number of patients (%)	6 (66.7%)	3 (100%)
Survival After ASCT, mean ± sem, months	24.01±2.97	39.55±7.12	0.691
Overall Survival, mean ± sem, months	49.73±6.09	92.27±14.65	0.441